{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:21:03Z","timestamp":1785403263309,"version":"3.56.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Mycology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.mycmed.2021.101232","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T11:50:10Z","timestamp":1638359410000},"page":"101232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Current scenario of the search for new antifungal agents to treat Candida auris infections: An integrative review"],"prefix":"10.1016","volume":"32","author":[{"given":"Daniel Clemente","family":"de Moraes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2021.101232_bib0001","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1128\/jcm.29.8.1702-1710.1991","article-title":"Genetic dissimilarity of commensal strains of Candida spp. carried in different anatomical locations of the same healthy women","volume":"29","author":"Soll","year":"1990","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2021.101232_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092345","article-title":"Divergent approaches to virulence in C. albicans and C. glabrata: Two sides of the same coin","volume":"20","author":"Galocha","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.mycmed.2021.101232_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-019-4710-z","article-title":"Antifungal resistance in patients with Candidaemia: A retrospective cohort study","volume":"20","author":"Aldardeer","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.mycmed.2021.101232_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0224678","article-title":"Candida blood stream infections observed between 2011 and 2016 in a large Italian University Hospital: A time-based retrospective analysis on epidemiology, biofilm production, antifungal agents consumption and drug-susceptibility","volume":"14","author":"Brunetti","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.mycmed.2021.101232_bib0005","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bjm.2015.05.001","article-title":"Candida glabrata among Candida spp. From environmental health practitioners of a Brazilian hospital","volume":"47","author":"Savastano","year":"2016","journal-title":"Brazilian J Microbiol"},{"key":"10.1016\/j.mycmed.2021.101232_bib0006","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1348-0421.2008.00083.x","article-title":"Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital","volume":"53","author":"Satoh","year":"2009","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.mycmed.2021.101232_bib0007","doi-asserted-by":"crossref","first-page":"805","DOI":"10.4065\/mcp.2011.0247","article-title":"Current concepts in antifungal pharmacology","volume":"86","author":"Lewis","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.mycmed.2021.101232_bib0008","doi-asserted-by":"crossref","first-page":"6","DOI":"10.15585\/mmwr.mm6901a2","article-title":"Candida auris Isolates Resistant to Three Classes of Antifungal Medications \u2014 New York, 2019","volume":"69","author":"Ostrowsky","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.mycmed.2021.101232_bib0009","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13054-019-2449-y","article-title":"The global challenge of Candida auris in the intensive care unit","volume":"23","author":"Cortegiani","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.mycmed.2021.101232_bib0010","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1017\/ice.2017.162","article-title":"Effectiveness of disinfectants against candida auris and other candida species","volume":"38","author":"Cadnum","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.mycmed.2021.101232_bib0011","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3390\/microorganisms9040807","article-title":"Candida auris: Epidemiology, Diagnosis, Pathogenesis, Antifungal Susceptibility, and Infection Control Measures to Combat the Spread of Infections in Healthcare Facilities","volume":"9","author":"Ahmad","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.mycmed.2021.101232_bib0012","first-page":"546","article-title":"The integrative review: updated methodology","volume":"52","author":"Whittermore","year":"2005","journal-title":"Methodol Issues Nurs Res"},{"key":"10.1016\/j.mycmed.2021.101232_bib0013","first-page":"7","article-title":"An Integrative Literature Review Framework for Postgraduate Nursing Research Reviews","volume":"5","author":"Dela","year":"2017","journal-title":"Eur J Res Med Sci"},{"key":"10.1016\/j.mycmed.2021.101232_bib0014","doi-asserted-by":"crossref","first-page":"21183","DOI":"10.1021\/acsami.9b20708","article-title":"Inhibition of Candida auris Biofilm Formation on Medical and Environmental Surfaces by Silver Nanoparticles","volume":"12","author":"Lara","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.mycmed.2021.101232_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2020.01673","article-title":"Silver Nanoantibiotics Display Strong Antifungal Activity Against the Emergent Multidrug-Resistant Yeast Candida auris Under Both Planktonic and Biofilm Growing Conditions","volume":"11","author":"Vazquez-Munoz","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.mycmed.2021.101232_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mSphere.00539-18","article-title":"Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens","volume":"3","author":"Mamouei","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.mycmed.2021.101232_bib0017","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1080\/21505594.2020.1838741","article-title":"Aprepitant, an antiemetic agent, interferes with metal ion homeostasis of Candida auris and displays potent synergistic interactions with azole drugs","volume":"11","author":"Eldesouky","year":"2020","journal-title":"Virulence"},{"key":"10.1016\/j.mycmed.2021.101232_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-20183-3","article-title":"An oxindole efflux inhibitor potentiates azoles and impairs virulence in the fungal pathogen Candida auris","volume":"11","author":"Iyer","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.mycmed.2021.101232_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01457-17","article-title":"Evaluation of antifungal efficacy of three new cyclic lipopeptides of the class bacillomycin from Bacillus subtilis RLID 12.1","volume":"62","author":"Ramachandran","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0020","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/08927014.2020.1759559","article-title":"Antifungal evaluation of traditional herbal monomers and their potential for inducing cell wall remodeling in Candida albicans and Candida auris","volume":"36","author":"Liu","year":"2020","journal-title":"Biofouling"},{"key":"10.1016\/j.mycmed.2021.101232_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics9080461","article-title":"Bismuth nanoantibiotics display anticandidal activity and disrupt the biofilm and cell morphology of the emergent pathogenic yeast Candida auris","volume":"9","author":"Vazquez-Munoz","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.mycmed.2021.101232_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2019.105865","article-title":"In vitro characterization, ADME analysis, and histological and toxicological evaluation of BM1, a macrocyclic amidinourea active against azole-resistant Candida strains","volume":"55","author":"Orofino","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.mycmed.2021.101232_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-58203-3","article-title":"Improved efficacy of antifungal drugs in combination with monoterpene phenols against Candida auris","volume":"10","author":"Shaban","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.mycmed.2021.101232_bib0024","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/mmy\/myaa014","article-title":"Cathelicidin-inspired antimicrobial peptides as novel antifungal compounds","volume":"58","author":"Van Eijk","year":"2020","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2021.101232_bib0025","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/jac\/dky085","article-title":"Ceragenins are active against drug-resistant Candida auris clinical isolates in planktonic and biofilm forms","volume":"73","author":"Hashemi","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2019.00083","article-title":"Identification of Off-Patent Compounds That Present Antifungal Activity Against the Emerging Fungal Pathogen Candida auris","volume":"9","author":"Oliveira","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.mycmed.2021.101232_bib0027","doi-asserted-by":"crossref","first-page":"19081","DOI":"10.1021\/acsomega.9b02201","article-title":"Design of a Helical-Stabilized, Cyclic, and Nontoxic Analogue of the Peptide Cm-p5 with Improved Antifungal Activity","volume":"4","author":"Vicente","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.mycmed.2021.101232_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics9070363","article-title":"Derivates of the antifungal peptide CM-p5 inhibit development of Candida auris biofilms in vitro","volume":"9","author":"Kubiczek","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.mycmed.2021.101232_bib0029","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202000005","article-title":"A Cerberus-Inspired Anti-Infective Multicomponent Gatekeeper Hydrogel against Infections with the Emerging \u201cSuperbug\u201d Yeast Candida auris","volume":"20","author":"Kubiczek","year":"2020","journal-title":"Macromol Biosci"},{"key":"10.1016\/j.mycmed.2021.101232_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105901","article-title":"Colistin interacts synergistically with echinocandins against Candida auris","volume":"55","author":"Bidaud","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.mycmed.2021.101232_bib0031","doi-asserted-by":"crossref","unstructured":"Schwarz P., Bidaud A.L., Dannaoui E. In vitro synergy of isavuconazole in combination with colistin against Candida auris. Sci Rep 2020; 10:1\u20138. doi:10.1038\/s41598-020-78588-5","DOI":"10.1038\/s41598-020-78588-5"},{"key":"10.1016\/j.mycmed.2021.101232_bib0032","article-title":"Effects of the natural peptide crotamine from a south american rattlesnake on Candida auris, an emergent multidrug antifungal resistant human pathogen","volume":"9","author":"Colombo","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.mycmed.2021.101232_bib0033","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1021\/acs.biomac.9b01724","article-title":"Synthesis of Silver Nanoparticles Using Curcumin-Cyclodextrins Loaded into Bacterial Cellulose-Based Hydrogels for Wound Dressing Applications","volume":"21","author":"Gupta","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.mycmed.2021.101232_bib0034","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1021\/acs.jmedchem.9b01436","article-title":"Distorted Gold(I)-Phosphine Complexes as Antifungal Agents","volume":"63","author":"Dennis","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.mycmed.2021.101232_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01084-18","article-title":"Screening a repurposing library for inhibitors of multidrug-resistant Candida auris identifies ebselen as a repositionable candidate for antifungal drug development","volume":"62","author":"Wall","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2020.00957","article-title":"In vitro and in vivo Effect of Exogenous Farnesol Exposure Against Candida auris","volume":"11","author":"Nagy","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.mycmed.2021.101232_bib0037","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/mmy\/myz057","article-title":"Farnesol increases the activity of echinocandins against Candida auris biofilms","volume":"58","author":"Nagy","year":"2020","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2021.101232_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0233102","article-title":"Abrogation of pathogenic attributes in drug resistant Candida auris strains by farnesol","volume":"15","author":"Srivastava","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.mycmed.2021.101232_bib0039","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/cmdc.202000626","article-title":"Broad-Spectrum Antifungal Agents: Fluorinated Aryl- and Heteroaryl-Substituted Hydrazones","volume":"16","author":"Chandrika","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.mycmed.2021.101232_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2019.00414","article-title":"Potential of Gallium as an Antifungal Agent","volume":"9","author":"Bastos","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.mycmed.2021.101232_bib0041","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s11046-019-00370-7","article-title":"In Vitro Interaction of Geldanamycin with Triazoles and Echinocandins Against Common and Emerging Candida Species","volume":"184","author":"Mahmoudi","year":"2019","journal-title":"Mycopathologia"},{"key":"10.1016\/j.mycmed.2021.101232_bib0042","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1021\/acsinfecdis.0c00229","article-title":"Herbicides That Target Acetohydroxyacid Synthase Are Potent Inhibitors of the Growth of Drug-Resistant Candida auris","volume":"6","author":"Agnew-Francis","year":"2020","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.mycmed.2021.101232_bib0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01872-17","article-title":"Fluconazole-resistant Candida auris is susceptible to salivary histatin 5 killing and to intrinsic host defenses","volume":"62","author":"Pathirana","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0044","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00854-20","article-title":"Efficacy of ibrexafungerp (SCY-078) against Candida auris in an in vivo guinea pig cutaneous infection model","volume":"64","author":"Ghannoum","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02136-19","article-title":"In vitro activity of ibrexafungerp (SCY-078) against Candida auris isolates as determined by EUCAST methodology and comparison with activity against C. albicans and C. glabrata and with the activities of six comparator agents","volume":"64","author":"Arendrup","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0046","first-page":"7","article-title":"In vitro activity of a novel glucan synthase inhibitor, SCY-078, against clinical isolates of Candida auris","volume":"61","author":"Berkhow","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105922","article-title":"Pan-resistant Candida auris isolates from the outbreak in New York are susceptible to ibrexafungerp (a glucan synthase inhibitor)","volume":"55","author":"Zhu","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.mycmed.2021.101232_bib0048","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02396-16","article-title":"The emerging pathogen Candida auris: Growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation","volume":"61","author":"Larkin","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0049","doi-asserted-by":"crossref","DOI":"10.3390\/jof5040092","article-title":"Repositionable compounds with antifungal activity against multidrug resistant Candida auris identified in the medicines for malaria venture's pathogen box","volume":"5","author":"Wall","year":"2019","journal-title":"J Fungi"},{"key":"10.1016\/j.mycmed.2021.101232_bib0050","article-title":"Potent synergistic interactions between lopinavir and azole antifungal drugs against emerging multidrug-resistant Candida auris","volume":"65","author":"Eldesouky","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0051","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01124-20","article-title":"Evaluation of in vitro activity of manogepix against multidrug-resistant and panresistant Candida auris from the new york outbreak","volume":"64","author":"Zhu","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01225-18","article-title":"APX001A in vitro activity against contemporary blood isolates and Candida auris determined by the EUCAST reference method","volume":"62","author":"Arendrup","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01120-19","article-title":"Efficacy of Delayed Therapy with Fosmanogepix (APX001) in a Murine Model of Candida auris Invasive Candidiasis","volume":"63","author":"Wiederhold","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0054","first-page":"1","article-title":"In vivo pharmacokinetics and pharmacodynamics of APX001 against Candida spp. in a neutropenic disseminated candidiasis mouse model","volume":"62","author":"Zhao","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0055","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1093\/jac\/dky302","article-title":"Activity of novel antifungal compound APX001A against a large collection of Candida auris","volume":"73","author":"Berkow","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02319-17","article-title":"In vitro and in vivo evaluation of the antifungal activity of APX001A\/APX001 against Candida auris","volume":"62","author":"Hager","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0057","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00656-20","article-title":"APX001A) in Vitro Activity against Candida auris: Head-to-Head Comparison of EUCAST and CLSI MICs","volume":"64","author":"Arendrup","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0058","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02331-19","article-title":"Derivatives of the Antimalarial Drug Mefloquine Are Broad- Spectrum Antifungal Molecules with Activity against Drug-Resistant Clinical Isolates","volume":"64","author":"Montoya","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106049","article-title":"Miltefosine as an alternative strategy in the treatment of the emerging fungus Candida auris","volume":"56","author":"Barreto","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.mycmed.2021.101232_bib0060","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02063-19","article-title":"In vitro antifungal susceptibility of the emerging multidrug-resistant pathogen Candida auris to miltefosine alone and in combination with amphotericin B","volume":"64","author":"Wu","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0061","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01975-18","article-title":"In Vitro Activity of a Novel Antifungal Compound, MYC-053, against Clinically Significant Antifungal-Resistant Strains of Candida glabrata, Candida auris, Cryptococcus neoformans, and Pneumocystis spp","volume":"63","author":"Tetz","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0062","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jof6020085","article-title":"NO Candida auris: Nitric oxide in nanotherapeutics to combat emerging fungal pathogen Candida auris","volume":"6","author":"Cleare","year":"2020","journal-title":"J Fungi"},{"key":"10.1016\/j.mycmed.2021.101232_bib0063","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1021\/acsmedchemlett.0c00449","article-title":"Novel 2-Aryloxazoline Compounds Exhibit an Inhibitory Effect on Candida spp., including Antifungal-Resistant Isolates","volume":"11","author":"Argomedo","year":"2020","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.mycmed.2021.101232_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112046","article-title":"Oxadiazolylthiazoles as novel and selective antifungal agents","volume":"189","author":"Hagras","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.mycmed.2021.101232_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-62976-y","article-title":"Ospemifene displays broad-spectrum synergistic interactions with itraconazole through potent interference with fungal efflux activities","volume":"10","author":"Eldesouky","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.mycmed.2021.101232_bib0066","doi-asserted-by":"crossref","unstructured":"Revie N.M., Robbins N., Whitesell L., et\u00a0al. Oxadiazole-containing macrocyclic peptides potentiate azole activity against pathogenic Candida species. mSphere 2020; 5:e00256-20. doi:10.1128\/mSphere.00256-20","DOI":"10.1128\/mSphere.00256-20"},{"key":"10.1016\/j.mycmed.2021.101232_bib0067","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1093\/jac\/dkz280","article-title":"In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris","volume":"74","author":"Rudramurthy","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0068","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00223-18","article-title":"Peptide-like nylon-3 polymers with activity against phylogenetically diverse, intrinsically drug-resistant pathogenic fungi","volume":"3","author":"Rank","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.mycmed.2021.101232_bib0069","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-55379-1","article-title":"Identification of a Phenylthiazole Small Molecule with Dual Antifungal and Antibiofilm Activity Against Candida albicans and Candida auris","volume":"9","author":"Mohammad","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.mycmed.2021.101232_bib0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jare.2020.11.002","article-title":"Piperidine based 1,2,3-triazolylacetamide derivatives induce cell cycle arrest and apoptotic cell death in Candida auris","volume":"29","author":"Srivastava","year":"2020","journal-title":"J Adv Res"},{"key":"10.1016\/j.mycmed.2021.101232_bib0071","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1093\/jac\/dkz390","article-title":"In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiae","volume":"74","author":"T\u00f3th","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0072","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/jac\/dky153","article-title":"Evaluation of the efficacy of rezafungin, a novel echinocandin, in the treatment of disseminated Candida auris infection using an immunocompromised mouse model","volume":"73","author":"Hager","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0073","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01572-18","article-title":"Pharmacodynamic Evaluation of Rezafungin (CD101) against Candida auris in the Neutropenic Mouse Invasive Candidiasis Model","volume":"62","author":"Lepak","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0074","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.diagmicrobio.2017.10.021","article-title":"Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida auris","volume":"90","author":"Berkow","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.mycmed.2021.101232_bib0075","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02438-19","article-title":"Rezafungin in vitro activity against contemporary nordic clinical Candida isolates and Candida auris determined by the EUCAST reference method","volume":"64","author":"Helleberg","year":"2020","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0076","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.03329-19","article-title":"Translation inhibition by rocaglates activates a species-specific cell death program in the emerging fungal pathogen Candida auris","volume":"11","author":"Iyer","year":"2020","journal-title":"MBio"},{"key":"10.1016\/j.mycmed.2021.101232_bib0077","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/jam.14490","article-title":"Sertraline as a promising antifungal agent: inhibition of growth and biofilm of Candida auris with special focus on the mechanism of action in vitro","volume":"128","author":"Gowri","year":"2020","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.mycmed.2021.101232_bib0078","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/jam.14870","article-title":"Antifungal and anti-biofilm effects of 6-shogaol against Candida auris","volume":"130","author":"Kim","year":"2021","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.mycmed.2021.101232_bib0079","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ijantimicag.2018.08.016","article-title":"Synergistic interactions of sulfamethoxazole and azole antifungal drugs against emerging multidrug-resistant Candida auris","volume":"52","author":"Eldesouky","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.mycmed.2021.101232_bib0080","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02198-19","article-title":"The novel arylamidine T-2307 demonstrates in vitro and in vivo activity against Candida auris","volume":"64","author":"Wiederhold","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0081","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.abd6919","article-title":"A marine microbiome antifungal targets urgent-threat drug-resistant fungi","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.mycmed.2021.101232_bib0082","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3390\/molecules25061463","article-title":"Essential Oil-Based Design and Development of Novel anti-Candida Azoles Formulation","volume":"25","author":"Hamdy","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.mycmed.2021.101232_bib0083","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02233-18","article-title":"The fungal Cyp51-specific inhibitor VT-1598 demonstrates in vitro and in vivo activity against Candida auris","volume":"63","author":"Wiederhold","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0084","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00111-18","article-title":"Fungicidal potency and mechanisms of defensins against multidrug-resistant Candida species","volume":"62","author":"Basso","year":"2018","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0085","doi-asserted-by":"crossref","DOI":"10.3390\/jof7050322","article-title":"In vivo efficacy of Lacticaseibacillus rhamnosus l8020 in a mouse model of oral candidiasis","volume":"7","author":"Ito","year":"2021","journal-title":"J Fungi"},{"key":"10.1016\/j.mycmed.2021.101232_bib0086","first-page":"1","article-title":"Animal Models in Pharmacology: A Brief History Awarding the Nobel Prizes for Physiology or Medicine","volume":"2021","author":"Baptista","year":"2021","journal-title":"Pharmacology"},{"key":"10.1016\/j.mycmed.2021.101232_bib0087","article-title":"Current strategies in assessment of nanotoxicity: Alternatives to in vivo animal testing","volume":"22","author":"Huang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.mycmed.2021.101232_bib0088","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural Products as Sources of New Drugs over the Nearly Four Decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J Nat Prod"},{"key":"10.1016\/j.mycmed.2021.101232_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104240","article-title":"History of the development of antifungal azoles: A review on structures, SAR, and mechanism of action","volume":"104","author":"Shafiei","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.mycmed.2021.101232_bib0090","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1590\/0001-3765201520140717","article-title":"Prevalence and fluconazole susceptibility profile of Candida spp. Clinical isolates in a Brazilian tertiary hospital in Minas Gerais, Brazil","volume":"87","author":"Neves-Junior","year":"2015","journal-title":"An Acad Bras Cienc"},{"key":"10.1016\/j.mycmed.2021.101232_bib0091","first-page":"988","article-title":"Pan-azole-resistant Candida tropicalis carrying homozygous erg11 mutations at position K143R: A new emerging superbug?","volume":"72","author":"Xisto","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0092","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.mycmed.2019.07.004","article-title":"Insights on the anticandidal activity of non-antifungal drugs","volume":"29","author":"Moraes","year":"2019","journal-title":"J Mycol Med"},{"key":"10.1016\/j.mycmed.2021.101232_bib0093","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1128\/AAC.02145-13","article-title":"Enfumafungin derivative MK-3118 shows increased in vitro potency against clinical echinocandin-resistant candida species and aspergillus species isolates","volume":"58","author":"Jim\u00e9nez-Ortigosa","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0094","unstructured":"ClinicalTrials.gov. Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida auris (CARES), https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT03363841 [acessed 18 November 2021 ]."},{"key":"10.1016\/j.mycmed.2021.101232_bib0095","unstructured":"ClinicalTrials.gov. Study of Rezafungin Compared to Caspofungin in Subjects with Candidemia and\/or Invasive Candidiasis (ReSTORE), https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03667690 [acessed 18 November 2021 ]."},{"key":"10.1016\/j.mycmed.2021.101232_bib0096","unstructured":"ClinicalTrials.gov. Open-Label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds (AEGIS), https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04240886 [acessed 18 november 2021 ]."},{"key":"10.1016\/j.mycmed.2021.101232_bib0097","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1128\/AAC.01497-08","article-title":"Curcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals","volume":"53","author":"Sharma","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0098","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1128\/AAC.05706-11","article-title":"The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates","volume":"56","author":"Holmes","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0099","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0100","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/CMR.00051-08","article-title":"Efflux-mediated antifungal drug resistance","volume":"22","author":"Cannon","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.mycmed.2021.101232_bib0101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0202993","article-title":"ABC transportome inventory of human pathogenic yeast Candida glabrata: Phylogenetic and expression analysis","volume":"13","author":"Kumari","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.mycmed.2021.101232_bib0102","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nm0410-347","article-title":"Mechanism matters","volume":"16","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.mycmed.2021.101232_bib0103","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4161\/viru.22913","article-title":"Candida albicans pathogenicity","volume":"4","author":"Mayer","year":"2013","journal-title":"Virulence"},{"key":"10.1016\/j.mycmed.2021.101232_bib0104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3402\/jom.v3i0.5771","article-title":"Pathogenesis and treatment of oral candidosis","volume":"3","author":"Williams","year":"2011","journal-title":"J Oral Microbiol"},{"key":"10.1016\/j.mycmed.2021.101232_bib0105","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.mycmed.2018.03.004","article-title":"b -lapachone and a -nor-lapachone modulate Candida albicans viability and virulence factors","volume":"28","author":"Moraes","year":"2018","journal-title":"J Mycol Med"},{"key":"10.1016\/j.mycmed.2021.101232_bib0106","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/EC.05030-11","article-title":"Modulation of morphogenesis in Candida albicans by various small molecules","volume":"10","author":"Shareck","year":"2011","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.mycmed.2021.101232_bib0107","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.mib.2006.10.003","article-title":"How to build a biofilm: a fungal perspective","volume":"9","author":"Blankenship","year":"2006","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.mycmed.2021.101232_bib0108","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1128\/AAC.01638-09","article-title":"Interaction of Candida albicans biofilms with antifungals: Transcriptional response and binding of antifungals to beta-glucans","volume":"54","author":"Vediyappan","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0109","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1128\/IAI.71.8.4333-4340.2003","article-title":"Mechanism of fluconazole resistance in Candida albicans biofilms: Phase-specific role of efflux pumps and membrane sterols","volume":"71","author":"Mukherjee","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.mycmed.2021.101232_bib0110","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1128\/AAC.00684-06","article-title":"Candida albicans biofilms produce antifungal-tolerant persister cells","volume":"50","author":"LaFleur","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2021.101232_bib0111","doi-asserted-by":"crossref","DOI":"10.1038\/s41426-018-0187-x","article-title":"Filamentation in Candida auris, an emerging fungal pathogen of humans: passage through the mammalian body induces a heritable phenotypic switch","volume":"7","author":"Yue","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.mycmed.2021.101232_bib0112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jof7060401","article-title":"Pathogenicity assessment of colombian strains of candida auris in the galleria mellonella invertebrate model","volume":"7","author":"Carvajal","year":"2021","journal-title":"J Fungi"}],"container-title":["Journal of Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523321001232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523321001232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:22:04Z","timestamp":1761110524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523321001232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":112,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1156523321001232"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2021.101232","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current scenario of the search for new antifungal agents to treat Candida auris infections: An integrative review","name":"articletitle","label":"Article Title"},{"value":"Journal of Medical Mycology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2021.101232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 SFMM. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101232"}}